FBIOP

#7311
Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
19.4 7 USD
+0.67%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
19.42
19.48
년간 변동
6.27
19.48
일일 변동
+0.67%
월간 변동
+35.21%
6달 변화
+180.95%
년간 변동율
+180.55%
이전 종가
19.3 4
Open
19.4 3
저가
19.4 2
High
19.4 8
양
17
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 102.61 M
  • Employee 78
  • Founded 2006
  • CEO Lindsay Rosenwald
  • Website www.fortressbiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MFH6
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-135.57
주가매출액비율
4.19

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

뉴스